Pre-market · Oct 6, 4:10 am ET · After hours $23.40 +0.43%
Open$23.98
Prev close$23.63
Day range$22.97 – $24.00
Volume1.08M
Market cap$2.06B
P/E (TTM)–
Dividend yield–
MLYS Stock News
Headlines matching Mineralys Therapeutics or the MLYS ticker, most recent first.
Mineralys Therapeutics(MLYS.US) Director Sells US$3.01 Million in Common StockMarket news · 25 Sep 2026
Form 144 | Mineralys Therapeutics(MLYS.US) Director Proposes to Sell 3.01 Million in Common StocksMarket news · 23 Sep 2026
Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)TipRanks · 13 Aug 2026
A Quick Look at Today's Ratings for Mineralys Therapeutics(MLYS.US), With a Forecast Between $40 to $56Market news · 13 Aug 2026
Bank of America Securities Sticks to Its Buy Rating for Mineralys Therapeutics, Inc. (MLYS)TipRanks · 12 Aug 2026
LifeSci Capital Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating, Maintains Target Price $54Market news · 12 Aug 2026
Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (ISRG), Legend Biotech (LEGN) and Mineralys Therapeutics, Inc. (MLYS)TipRanks · 12 Aug 2026
H.C. Wainwright Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating, Maintains Target Price $56Market news · 12 Aug 2026
Mineralys Therapeutics, Inc. (MLYS) Gets a Buy From Wells FargoTipRanks · 12 Aug 2026
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Mineralys Therapeutics, Inc. (MLYS) and ArriVent BioPharma, Inc. (AVBP)TipRanks · 4 Jun 2026
Goldman Sachs Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating, Maintains Target Price $42Market news · 4 Jun 2026
A Quick Look at Today's Ratings for Mineralys Therapeutics(MLYS.US), With a Forecast Between $42 to $56Market news · 8 May 2026
Analysts Have Conflicting Sentiments on These Healthcare Companies: Collegium Pharmaceutical (COLL), Myriad Genetics (MYGN) and Mineralys Therapeutics, Inc. (MLYS)TipRanks · 8 May 2026
Analysts Are Bullish on These Healthcare Stocks: Mineralys Therapeutics, Inc. (MLYS), Context Therapeutics (CNTX)TipRanks · 7 May 2026
TD Cowen Maintains Mineralys Therapeutics(MLYS.US) With Buy RatingMarket news · 7 May 2026
Discussion
No comments yet — be the first to weigh in on MLYS.
No comments yet — be the first to weigh in on MLYS.